Oncology and Hematology Associates of Southwest Virginia, INC.

Oncology and Hematology Associates of Southwest Virginia, INC. was paid $2.71M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,265	$127K
2019	22,463	$465K
2020	17,552	$386K
2021	20,775	$428K
2022	23,215	$528K
2023	24,633	$491K
2024incomplete	15,250	$287K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	30%	15,220	12,442	$817K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	27%	10,204	6,768	$725K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	13%	9,749	8,358	$345K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	8.7%	40,735	28,873	$237K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	4.1%	1,452	1,115	$111K
96375	Therapeutic injection; each additional sequential IV push	3.6%	5,264	3,442	$99K
77014		3.5%	3,901	709	$96K
80053	Comprehensive metabolic panel	3.1%	17,161	13,183	$84K
77427		2.8%	717	334	$76K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	660	538	$25K
96367		<1%	870	586	$19K
36415	Collection of venous blood by venipuncture	<1%	14,238	12,506	$17K

25 more codes

J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,663	$8K
99204	Doctor's office visit, new patient (more involved)	<1%	94	$8K
82728		<1%	1,043	$8K
J0185	Injection, aprepitant, 1 mg	<1%	21	$4K
83550		<1%	840	$4K
99195		<1%	61	$4K
77263		<1%	43	$4K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	196	$4K
83540		<1%	828	$3K
77300		<1%	45	$3K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	411	$2K
J1453	Injection, fosaprepitant, 1 mg	<1%	26	$2K
36416		<1%	5,239	$2K
77334		<1%	20	$1K
99205	Prolong outpt/office vis	<1%	19	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	26	$826.83
77290		<1%	14	$746.48
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	96	$592.41
99232	Hospital visit by a doctor, follow-up day	<1%	33	$560.73
82607		<1%	41	$263.74
99441		<1%	19	$155.48
J7030	Infusion, normal saline solution , 1000 cc	<1%	58	$107.41
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	115	$61.99
J3490	Unclassified drugs	<1%	18	$21.30
G9678	Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOUSMAN-BUSSEY, TIFFANY (REVENUE CYCLE MANAGER)